COVID-19 (coronavirus disease 2019) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1][2]. The disease has spread globally since late 2019 and presents significant challenges for healthcare systems worldwide [1][2].
Disease overview
Other viral diseases
其他病毒性疾病
Evidence-backed informationEN 1/5 applicable sections · ZH 1/5 applicable sectionsUpdated Sep 3, 2026
The ongoing COVID-19 pandemic, caused by SARS-CoV-2, represents a major global health crisis that has exposed vulnerabilities in healthcare systems worldwide [1][2]. Remdesivir is the first approved treatment for severe COVID-19, representing an important therapeutic milestone, though further scientific efforts are needed to develop additional effective antivirals [1]. Rapid development of diagnostic methods, including PCR, LAMP, LFIA, ELISA, biosensors, and CLIA, has been essential for identifying cases across diverse sample types [2]. The emergence of other antiviral candidates continues to expand the therapeutic toolkit against this and related respiratory pathogens [1][3].
Read the full clinical and epidemiological profile2
- 1Malin JJ et al. Remdesivir against COVID-19 and Other Viral Diseases. Clin Microbiol Rev. 2020 Dec 16. PMID: 33055231. doi: 10.1128/CMR.00162-20.PubMed: https://pubmed.ncbi.nlm.nih.gov/33055231/
- 2Pohanka M et al. COVID-19 molecular level laboratory diagnoses. Bratisl Lek Listy. 2021. PMID: 33393315. doi: 10.4149/BLL_2021_025.PubMed: https://pubmed.ncbi.nlm.nih.gov/33393315/
- 3Wikipedia contributors. Merimepodib [Internet]. Wikipedia. cited 20 May 2026.Available from: https://en.wikipedia.org/wiki/Merimepodib
- 4Tharappel AM et al. Targeting Crucial Host Factors of SARS-CoV-2. ACS Infect Dis. 2020 Nov 13. PMID: 33112126. doi: 10.1021/acsinfecdis.0c00456.PubMed: https://pubmed.ncbi.nlm.nih.gov/33112126/
- B33
Data access
Page dataset index with source links and update metadata.